At the news
? NEUTRALIMPACT 3/10 PRESS-RELEASE filed Apr 27, 2026 at 08:00 ET
Evaxion promoted its Chief Scientific Officer, Birgitte Rønø, to also serve as Chief Operating Officer to enhance external engagement and strategic execution. The move reflects internal management restructuring but does not involve new financial or operational data.
- Birgitte Rønø, CSO, promoted to dual role of CSO and COO at Evaxion
- Promotion aims to strengthen external visibility and strategic execution of the AI-Immunology™ platform
- No changes to other executive roles; management team remains intact
- No financial metrics, guidance updates, or material operational changes disclosed
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access